Mimi Reyes

Reyes is a results-driven, growth-focused executive who has led global molecular operations, and executed strategic growth initiatives in regulated U.S. and international environments. Her expertise includes managing laboratories compliant with CAP, CLIA, FDA, ISO 9001, and ISO 13485 standards, as well as building and leading high-performing teams.

Prior to joining PreludeDx, Reyes served on the Executive Management team at MDxHealth, where she oversaw Global Operations and led diagnostic testing programs in prostate cancer, bladder cancer, and urinary tract infections. Earlier in her career, she was an early pioneer at Agendia, supporting the launch of MammaPrint for early-stage breast cancer testing, and held leadership roles at CombiMatrix and US LABS.